Verasonics Forms Partnership With PhotoSound Technologies

Verasonics Inc. is partnering with PhotoSound Technologies Inc. to offer customers the PhotoSound Legion AMP for use with Vantage and Vantage NXT Research Ultrasound Systems. The pairing offers Vantage customers expanded capabilities by integrating the Legion AMP128 in applications using photoacoustic imaging, thermoacoustic imaging, and monitoring radiation therapy, among others.

The Legion AMP128 is a 128-channel receive signal preamplifier for use with Vantage or Vantage NXT Research Ultrasound Systems, in all channel configurations. It features high input impedance and a fixed 40db gain that amplifies weak signals, especially in the lower frequency band with a high Signal to Noise Ratio (SNR). This is especially useful for research and development applications where a pulsed energy source is used where the excitation source is either weak or a long pulse.

“Adding a Legion AMP unit to a Vantage or Vantage NXT platform allows researchers to refine their receive capabilities, ensuring they are capturing key data,” Verasonics President/CEO Jon K. Daigle said. “This partnership will allow us to better serve our mutual customer base.”

“In thermo-, photo-, and optoacoustic imaging, lower frequency signals are often underrepresented because many systems don’t respond to them evenly. The Legion Amp maintains a consistent high SNR response across a broad frequency range, including below 100 kHz, which helps preserve the true shape and strength of the original signal,” PhotoSound Technologies CEO Peter Brecht added. “I’m excited about this new collaboration and believe it will result in interesting new discoveries.”

Verasonics is a privately held company founded in 2001, with headquarters in Kirkland, Wash. Deeming itself the leader in research ultrasound, the company provides researchers and developers with advanced and flexible tools for developing new algorithms and products used in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics. Verasonics also licenses its technology to companies for use in their commercial products. Researchers in countries across North and South America, Europe, Asia and Oceania routinely use Verasonics product solutions to advance the art and science of ultrasound through their own research efforts.

PhotoSound Technologies, Inc. was founded in September 2015 in Houston, Texas, to develop and commercialize new biomedical imaging technologies based on optics and photoacoustics. Photoacoustic tomography (PAT) is a biomedical imaging modality combining the molecular sensitivity of optical probes with ultrasound’s spatial resolution that is ideal for various applications that can be used for pre-clinical research. Using skills to successfully translate the technology from its experimental form, the firm develops biomedical systems and associated software, including imaging instrumentation, complex electronic boards for data acquisition and control, transducers, sensors, and tunable lasers.